We found that the mRNA expression levels of CMTM5 in breast cancer tissues were still significantly lower than in normal tissues after stratification by tumor stage, nodal stage, histologic subtypes, and breast cancer subtypes (Figures 5A–D). This evidence concerns the gene CMTM5 and breast cancer.